Neuphoria Therapeutics Inc
NASDAQ:NEUP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Neuphoria Therapeutics Inc
NASDAQ:NEUP
|
US |
|
B
|
Baan Rock Garden PCL
SET:BROCK
|
TH |
|
S
|
Spobag AG
DUS:SBE
|
DE |
|
Staffing 360 Solutions Inc
NASDAQ:STAF
|
US |
|
D
|
Delta Paint PCL
SET:DPAINT
|
TH |
|
AECOM
NYSE:ACM
|
US |
|
Norsk Hydro ASA
OSE:NHY
|
NO |
|
E
|
Empresa Distribuidora y Comercializadora Norte SA
BCBA:EDN
|
AR |
|
Ebusco Holding NV
F:8J3
|
NL |
|
STRABAG SE
OTC:STBBF
|
AT |
|
Marston's PLC
LSE:MARS
|
UK |
|
Aluflexpack AG
SIX:AFP
|
CH |
|
Kingsrose Mining Ltd
ASX:KRM
|
AU |
|
C
|
CEZ as
SWB:CEZ
|
CZ |
|
N
|
Nissan Chemical Corp
XBER:NSC
|
JP |
|
F
|
FendX Technologies Inc
OTC:FDXTF
|
CA |
|
Africa Energy Corp
XTSX:AFE
|
CA |
|
Elcora Advanced Materials Corp
F:ELM
|
CA |
|
P
|
Prakit Holdings PCL
SET:PRAKIT
|
TH |
|
D
|
Deutsche Cannabis AG
XBER:HEMP
|
DE |
|
C
|
Copperwired PCL
SET:CPW
|
TH |
|
E
|
EMP Metals Corp
CNSX:EMPS
|
CA |
|
B-R 31 Ice Cream Co Ltd
TSE:2268
|
JP |
|
O
|
OCC PCL
SET:OCC
|
TH |
Bankruptcy Probability
Neuphoria Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Neuphoria Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
N
|
Neuphoria Therapeutics Inc
NASDAQ:NEUP
|
20.3m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
456.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
236.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
184.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
138.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
56B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
82.5B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Neuphoria Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Neuphoria Therapeutics Inc has total debt of 34.2k USD. This includes both short-term (34.2k USD) and long-term (0 USD) debt.
You can find a full breakdown on its Balance Sheet.
